Dividend
-
-
-
-
-
-
-
Merrimack Reports Full Year 2023 Financial Results
-
-
-
-
-
-
-
Merrimack Pharmaceuticals Announces Per Share Amount for Previously Declared Special Dividend
-
-
-
-
-
-
-
Merrimack Provides Business Update and Reports 2017 Financial Results
-
-
-
-
-
-
-
Merrimack Reports First Quarter 2017 Financial Results
-
-
-
-
-
-
-
Merrimack Stockholders Approve Sale of ONIVYDE® and Generic Version of DOXIL® to Ipsen for Up to $1.025 Billion
-
-
-
-
-
-
-
Merrimack Concludes Strategic Review; Announces Plan to Divest Assets and Sharpen Strategic Focus
-
-
445,309 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

